Avidity Partners Management
Overview
Avidity Partners Management is a healthcare-focused hedge fund manager that invests in public and private biotechnology companies using a fundamental, bottom-up research approach.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CG Oncology | Aug 2023 | Crossover Round | Co-investor |
| UpStream | Dec 2022 | Series B | Co-investor |
| Calyxo | Dec 2023 | Series D | Lead |
| Sirona Medical | Nov 2024 | Series C | Lead |
| Nested Therapeutics | Oct 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Avidity Partners Management based?
Avidity Partners Management is headquartered in Dallas, Texas, United States.
When was Avidity Partners Management founded?
Avidity Partners Management was founded in 2019.
How many portfolio companies does Avidity Partners Management have?
Avidity Partners Management has 7 portfolio companies in Caplight's dataset.
What are some companies in Avidity Partners Management's portfolio?
Portfolio companies visible on Caplight include CG Oncology, UpStream, Calyxo, Sirona Medical, Nested Therapeutics.
What was Avidity Partners Management's most recent investment shown here?
Avidity Partners Management's most recent investment in this portfolio sample was in Sirona Medical in 2024.
What sectors does Avidity Partners Management focus on?
Avidity Partners Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Avidity Partners Management focus on?
Stage focus information for Avidity Partners Management is not publicly available.
What is Avidity Partners Management's AUM?
Avidity Partners Management's assets under management are estimated between $3.1B and $5.3B.